Multiple Myeloma

Feb 15, 2017 by in ONCOLOGY Comments Off on Multiple Myeloma

Figure 30-1 An outline of the main factors leading from multiple myeloma (MM) to monoclonal gammopathy of undetermined significance (MGUS); the distinction between HD and NHD MM; and finally additional…

read more

The Molecular Pathogenesis of Head and Neck Cancer

Feb 15, 2017 by in ONCOLOGY Comments Off on The Molecular Pathogenesis of Head and Neck Cancer

Figure 33-1 The Field Cancerization Theory is defined as the presence of one or more mucosal areas consisting of epithelial cells with cancer-associated genetic or epigenetic alterations. A precursor field…

read more

Cancer Immunotherapy with Vaccines and Checkpoint Blockade

Feb 15, 2017 by in ONCOLOGY Comments Off on Cancer Immunotherapy with Vaccines and Checkpoint Blockade

html xmlns=”http://www.w3.org/1999/xhtml”> 52 Cancer Immunotherapy with Vaccines and Checkpoint Blockade Drew Pardoll Therapeutic vaccination for cancer continues to be a major approach to the overall immunotherapy of cancer. Historically, interest…

read more

Molecular Basis for Treating Cutaneous Melanoma

Feb 15, 2017 by in ONCOLOGY Comments Off on Molecular Basis for Treating Cutaneous Melanoma

Figure 42-1 Development of melanoma Although melanomas can develop from melanocytes at the epidermal-dermal junction directly or in a preexisting nevus, an orderly progression from melanocyte to neoplasm (benign nevus)…

read more

Cellular Senescence

Feb 15, 2017 by in ONCOLOGY Comments Off on Cellular Senescence

Figure 15-1 Senescence stimuli and biological characteristics Senescence is induced by diverse endogenous and exogenous stresses that promote strong pro-proliferative signaling and DNA damage responses. Senescent cells undergo a permanent…

read more

Tumor Suppressor Genes

Feb 15, 2017 by in ONCOLOGY Comments Off on Tumor Suppressor Genes

A third interpretation of the role of haploinsufficiency in tumorigenesis is based on the exquisite sensitivity of cells to even small changes in the levels of some cancer-associated proteins. Thus,…

read more

Interferons

Feb 15, 2017 by in ONCOLOGY Comments Off on Interferons

html xmlns=”http://www.w3.org/1999/xhtml”> 53 Interferons Ernest C. Borden ∗ Introduction Interferons (IFNs) comprise a family of secreted α-helical cytokines induced in response to specific extracellular biomolecules through stimulation of Toll-like receptors…

read more

Pharmacogenomics

Feb 15, 2017 by in ONCOLOGY Comments Off on Pharmacogenomics

html xmlns=”http://www.w3.org/1999/xhtml”> 49 Pharmacogenomics Peter H. O’Donnell and Mark J. Ratain Introduction The term pharmacogenetics is believed to have first been used in 1959 by Vogel who defined it as…

read more

The Molecular Biology of Breast Cancer

Feb 15, 2017 by in ONCOLOGY Comments Off on The Molecular Biology of Breast Cancer

This table is not comprehensive, but provides an example of breast cancer multiplexed gene tests that are currently in development or have been commercialized. The type of sample, number of…

read more

Cell Growth

Feb 15, 2017 by in ONCOLOGY Comments Off on Cell Growth

Unlike tumor cells with PTEN loss, tumor cells that have lost TSC function are generally less belligerent. It is now accepted that this is due to negative feedback loops that…

read more
Get Clinical Tree app for offline access